KIC-KT grant for oligonucleotide analysis to Pirok and Gargano

In a joint effort, CAST scientists Bob Pirok and Andrea Gargano have been awarded funding for their InnovATOR project together with Prof. Govert Somsen and Prof. Anouk Rijs (VU Amsterdam).

In a joint effort, CASA scientists Govert Somsen and Anouk Rijs (VU Amsterdam), and Bob Pirok and Andrea Gargano (UvA) have been awarded funding for their project Innovative Analytics for Therapeutic Oligonucleotide Research (InnovATOR) from the Dutch Research Council NWO. In a consortium with AstraZeneca, Novartis, GSK, MS Vision and Tosoh, they will advance and combine novel analytical methods to make a next step in unravelling the molecular composition of oligonucleotide pharmaceuticals. The project was recently granted within the Key Technologies (KT) program of the Knowledge and Innovation Covenant (KIC), which is aimed at solving societal challenges. The total project budget is 1.2 M€ of which 360 k€ is provided by the participating companies.

Oligonucleotide-based drugs offer promise as revolutionary therapies for hitherto untreatable diseases. However, by their synthetic nature and inherent instability, these therapeutics are chemically very complex. To understand their function and activity, and guarantee quality and patient safety, full characterization of oligonucleotide drugs is essential. The consortium of academic and industrial researchers will develop new analytical strategies by combining cutting-edge multidimensional separations with advanced mass spectrometric techniques and smart optimization and data algorithms. Three PhD students will be appointed within the consortium; they will perform their research at the VU and UvA laboratories, and be seconded for several time periods to company labs to focus on implementing newly developed methods in industry. The project aims to deliver key analytical technologies that will ultimately safeguard drug efficacy and patients’ wellbeing.

Read the press release by the Dutch Science Council here.

Related Posts

Novel sequencing approach enables detailed characterization of PLGA co-polymers

CAST Scientst Masashi Serizawas was published in Macromolecules. Masashi presents a ‘polymer sequencing’ approach for analyzing the composition of PLGA copolymers in great detail. The method consists of controlled chemical degradation followed by reversed-phase liquid chromatography and high-resolution mass spectrometry (RPLC-HRMS) to arrive at an accurate characterisation of block-length distribution. The work provides a robust framework for the rational design of sequence-controlled PLGA for drug delivery and other advanced applications.

Microscale native SEC-HRMS to characterize immunoconjugates

In this study, CAST scientists Annika van der Zon et al., in collaboration with Bram Weijers and Danielle Vlugts (Amsterdam UMC), introduce a rapid, microscale aqueous size-exclusion chromatography–mass spectrometry (SEC-MS) method to measure chelator to antibody ratio in immunoconjugates.

Size-Resolved Surface Charge Analysis of Polymer Nanoparticles: From Fundamental Measurement to Collaborative Innovation

The study addresses size-resolved surface charge density (SCD) analysis of polymer nanoparticles (PNPs), revealing the significant variability of SCD that traditional methods overlook. By employing advanced capillary zone electrophoresis techniques, researchers can gain detailed insights into nanoparticle performance, benefiting applications in coatings, biomedical, and industrial contexts through collaborative innovations.